OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study

Leighl, N., Cho, B. C., Hiret, S., Han, J.-Y., Lee, K. H., Llacer Perez, C., Krebs, M. G., De Braud, F., Haura, E., Sanborn, R. E., Yang, J. C.-H., Shu, C. A., Goto, K., Nishio, M., Zhao, J., Wang, Z., Tomasini, P., Felip, E., Goldman, J. W., … Spira, A. I. (2023). OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study. Journal of Thoracic Oncology, 18(11), S93–S94. https://doi.org/10.1016/j.jtho.2023.09.105
Authors:
N. Leighl
Byoung Chul Cho
Sandrine Hiret
Ji‐Youn Han
Ki Hyeong Lee
Casilda Llácer Pérez
Matthew Krebs
Filippo de Braud
Eric B. Haura
Rachel E. Sanborn
J.C.-H. Yang
Catherine A. Shu
Keiko Goto
Makoto Nishio
J. Zhao
Z. Wang
P. Tomasini
Enriqueta Felip
Jonathan W. Goldman
Sai-Hong Ou
Michael Boyer
Grace Gao
Su Qu
Joshua C. Curtin
X. Lyu
Amy Roshak
R.W. Schnepp
Philip Kim
Jennifer A. Mertz
Meena Thayu
S. Martin Shreeve
Roland Knoblauch
Alexander I. Spira
Affiliated Authors:
Catherine A. Shu
Columbia Affiliation:
Subjects:
Advancements in Lung Cancer Research (OpenAlex Topic)
Diagnosis and Treatment of Lung Cancer (OpenAlex Topic)
Genomic Landscape of Cancer and Mutational Signatures (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtho.2023.09.105
DOI:
10.1016/j.jtho.2023.09.105
Journal:
Journal of Thoracic Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: